Background and mandate

Understanding complex biological processes involved in the progression of cancer is crucial for the health care system. However, human beings are still unsure of the precise sequence of events that cause healthy cells to become diseased or cancerous. Several pieces of evidence suggest a combined effect of the intrinsic molecular drivers, signal from the tumor microenvironment and the microbiome on tumor development and progression. Early detection and treatment has been effective in controlling the growth and relapse of several types of tumors. Next-generation sequencing (NGS) and other genomic technologies along with tumor imaging technologies have assisted researchers in identifying cancer at an early stage and developing various cancer directed interventions. Despite these advances, the incidence of cancer and mortality rate in the cancer patients continues to increase, and the World Health Organization has projected a 77% increase in global cancer burden by 2050. Such a staggering increase necessitates the community of oncologists and associated disciplines involved in cancer research, treatment and patient care to come forward and discuss various new avenues of managing and mitigating treatment refractory tumors. Of the various physiological systems, our immune system is robust and due to its plasticity it can favour either the host or the tumor depending on several extrinsic and intrinsic factors. Given this intricate balance, the tailoring of our immune system in favour of the host is believed to be of paramount significance in the management of cancer. Therefore, the main mandate of this conference is to discuss various modalities for developing transnationally viable cancer directed immune therapeutics for effective control of cancer in the community.

The conference will encompass preclinical and clinical models of tumors and identify detection and treatment modalities for various refractory cancers that are currently prevalent and expected to rise due to changing lifestyles. The conference will discuss various modalities that are currently available for the upliftment of the healthcare sector for developing cancer directed interventions. The conference will provide a forum for physicians and scientists to share their views and experiences in designing new immune – pharmaceuticals against cancers, potentially leading to collaboration among various national and international laboratories. With this outcome in mind, we have designed various sessions to cover topics that are not just limited to cancer as an isolated disease but also include idiopathic diseases associated with cancer progression. This conference aims to establish equitable collaboration with various national and international R&D labs and hospitals to conduct translational and clinical studies that are important for validating new pharmaceuticals against cancer.

ABOUT GLOBAL CANCER CONSORTIUM

In 2020, Markey Cancer Center (University of Kentucky) formed a Global Cancer Consortium with Tata Memorial Centre (Mumbai), Manipal Academy of Higher Education (MAHE) Manipal, Saroj Gupta Cancer Centre and Research Institute (Kolkata) in India, and Mayo Clinic Cancer Center in USA. GCC now includes China Medical University, Taiwan, Brown University Legorreta Cancer Center, Kansas University Cancer Center, and autonomous Chapters in South Asia, East Asia, North American, and Europe (https://glocacon.org) GCC fosters global transdisciplinary collaborations in cancer education, research, treatment, and community outreach to overcome cancer. Global Cancer Consortium Invites / encourage Scientists to join GCC South Asia Chapter Under: Membership Registration Form

  • SPEAKERS

    The conference would be befitted by the Galaxy / stalwarts of world-renowned Tumor biologist/ Immunologists who will share their scientific journey and update conference with their groundbreaking work on Cancer diagnosis / therapy.


  • NATIONAL/INTERNATIONAL FACULTY

    Dr. Ranjeet Sahoo, MD

    Dept of Medical Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

    Dr. Mahadev Rao, PhD

    Manipal Academy of Higher Education, Manipal, Karnataka, India

    Dr. Danny Welch, PhD

    Kansas University Cancer Center, Kansas City, Kansas, USA

    Dr. Vivek M. Rangnekar, PhD

    Markey Comprehensive Cancer Center, University of Kentucky, Lexington, KY, USA

    Dr. Deepam Pushpam, MD

    Dept of Medical Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

    Dr. Jyoti Kode, PhD

    ACTREC, Tata Memorial Centre, Navi Mumbai, Maharashtra, India

    Prof. Aklank Jain, PhD

    Dept of Zoology, Central University of Punjab, Bhatinda, India

    Dr. Ashok Kumar Sharma, PhD

    Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India

    Dr. Hemant Malhotra, MD

    President, Immuno-Oncology Society, Mahatma Gandhi Medical College, Jaipur, India

    Dr. S. Chiplunkar, PhD

    ACTREC, Tata Memorial Hospital, Mumbai, India

    Dr. Jyoti Bajpai, MD

    ACTREC, Tata Memorial Hospital, Mumbai, India

    Dr. Rahul Purwar, PhD

    India Institute of Technology, Mumbai, India

    Dr. Atul Sharma, MD

    Dept of Medical Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

    Dr. Prabhat Singh Malik, MD

    Dept of Medical Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

    Dr. Prof GK Rath, MD

    Dr B R Ambedkar Institute Rotary Cancer Hospital, All India India Institute of Medial Sciences, New Delhi, India

    Prof. Amit Awasthi, PhD

    Translational Health Science and Technology Institute, Faridabad, Haryana, India

    Dr. Mausami Bhardwaj, PhD

    National Institute of Cancer Prevention and Research, Noida, India

    Dr. Showkat Hussian, PhD

    National Institute of Cancer Prevention and Research, Noida, India

    Prof. Rana Pratap Singh, PhD

    Jawaharlal Nehru University, New Delhi, India

    Dr. Daman Saluja, PhD

    Dr Ambedkar Center for Biomedical Research, University of Delhi, India

    Dr. Amit Dutt, PhD

    Department of Genetics, University of Delhi, New Delhi, India

    Dr. Moshahid Alam Rizvi, PhD

    Jamia Millia Islamia, New Delhi, India

    Dr. Hari Kumar, PhD

    Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India

    Dr. Paban Agrewala, PhD

    Institute of Nuclear Medicine and Allied Sciences, New Delhi, India

    Dr. Rajender K. Motiani, PhD

    Regional Centre for Biotechnology, Faridabad, Haryana, India

    Dr. Tanmay Majumdar, PhD

    National Institute of Immunology, New Delhi, India

    Dr. Prof Alok C Bharti, PhD

    University of Delhi, New Delhi, India

    Prof Madan Mohan Chaturvedi, PhD

    University of Delhi, New Delhi, India

    Dr. Vividha Dubey, MD

    HCGs Hospitals, Bhavnagar Gujarat, India.


    Industry Partners

    Dr. Vigyan Mishra, MD

    Neuberg Diagnostics, Noida India

    Dr. Manju Singh, PhD

    BBL, New Delhi, India

  • Sightseeing: 1st February, 2025

  • WHO CAN ATTEND

    Students pursuing postgraduate degrees (MSc/MPharm/PharmD/MD/MS/MCh) and faculty working in the relevant areas of specialization. PhD/Research Scholars in any discipline of biological sciences (Health or Life Sciences, Biotechnology, Biochemistry, Microbiology, Pharmacy, Genetics) working in the relevant areas of specializations.

  • Major topics to be covered by the conference:

    • Tumor Microenvironment and immunity
    • Genetic Mutation in Tumor and its Burden
    • Cancer immunotherapy ( Immune check point antibody Therapy)
    • Challenges in Chemo/Radiotherapies
    • Stem cell/ CAR–T cells/Tumor macrophage therapy
    • Cancer Vaccines
    • Drug Resistance and Cancer therapy
    • Cancer Biomarkers
    • Immune conditioning by HSCT
    • Role of Artificial Intelligence in Cancer Diagnosis and therapy
    • Genomics, proteomics and Metabolomics of Cancer
    • Traditional and Alternative medicine in cancer therapy
    • Translational Cancer Research
    • Cardio Oncology

    The participants will benefit from the participation of national and international cancer experts and thought leaders.

  • REGISTRATION AND GUIDELINES

    Registration fees for the conference:

    • 5000* INR Academic Faculty
    • 10000 INR Industry Partners
    • 3000 INR Students/Postdocs (*20% discount for GCC Members Only)

    Registration fees are non-refundable:

    • Registration and payment through online only. Please visit:
    • Registration deadline: December 01, 2024

  • ORAL PAPER AND POSTER PRESENTATION

    • We welcome all delegates to submit abstracts of original work including case series and unique cases for oral/e-poster presentation.
    • All abstracts must be submitted electronically and the deadline for submission is 01 Dec, 2024.
    • Abstract text should not be more than 300 words and should include title, authors, affiliations, objectives, methodology, results, and conclusion.
    • All material must be the work of authors listed and should not be presented at any prior conference or published.
    • For abstract submission, please visit: Abstract Submission
    • The abstract will be reviewed by the Panel of Experts, and you will be notified regarding the acceptance by email along with the abstract number.
    • The best 5 submissions will be considered for oral proffered papers session.
    • There are attractive prizes for best paper and best poster

Organizers

Chief Patron
Dr. Ashok K Chauhan
Founder President, Amity Education Group Noida, India
Patron
Dr. Atul Chauhan
Chancellor, Amity University Noida, India
Patron
Dr. (Mrs.) Balvinder Shukla
Vice Chancellor, Amity University Uttar Pradesh Noida, India
Patron
Dr. W. Selvamurthy
President, Amity Science Technology Innovation Foundation, Amity University, Noida, India

Chair

Prof. BC Das,PhD
Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Noida, India

Convenor

Prof. Subhrajit Biswas, PhD
Amity Institute of Molecular Medicine and Stem cell Research, Amity University, Noida, India
Organizing Secretary
Prof. Hridayesh Prakash, PhD
Amity Centre for Translational Research, Amity University, Noida, India
Joint Organizing Secretary
Prof. Manoj Garg, PhD
Amity Institute of Molecular Medicine and Stem cell Research, Amity University, Noida, India
Dr. Navkiran Kaur, Amity Institute of Biotechnology, Amity University, Noida, India
Treasurer
Dr. Sonia Kapoor, PhD
Amity Institute of Molecular Medicine and Stem cell Research, Amity University, Noida, India

Local Organizing committee

Dr. Pallavi Agarawal, PhD

Amity Institute of Molecular Medicine and Stem cell Research, Amity University, Noida , India

Dr. Havagiray R.  Chitme, PhD

Amity Institute of Pharmacy, Amity University, Noida, India

Dr. Tanveer Naved, PhD

Amity Institute of Pharmacy, Amity University, Noida, India

Dr. Vinit Kumar, PhD

Amity Institute of Molecular Medicine and Stem cell Research, Amity University, Noida , India

Dr. Prakash N Baligar, PhD

Amity Institute of Molecular Medicine and Stem cell Research, Amity University, Noida, India

Dr. M.K Dutta , PhD

Amity Centre for Artificial Intelligence, Amity University, Noida, India

Dr. Pooja V, PhD

Amity Institute of Biotechnology, Amity University, Noida, India

Dr. Gayatri Sharma, PhD

Amity Institute of Biotechnology, Amity University, Noida, India

Dr. Sandhya Singh, PhD

Amity Institute of Physiology, Amity University, Noida, India

Dr. Monalisa Mukherjee, PhD

Amity Institute of Click Chemistry, Amity University, Noida, India

Dr. Devinder Toor, PhD

Amity Institute of Virology and Immunology, Amity University, Noida, India


  • Last date for Registration: 15th November 2024
  • Abstract submission deadline: 1st December 2024
  • Notification of acceptance: 10th December 2024
  • Conference duration: 29-30th January 2025

VENUE

I-2 Moot Court/E-2 Auditorium Amity University, Sector 125, NOIDA, 201303, Uttar Pradesh India

Reach us

CONFERENCE SECRETARIAT

ACTR 5th GCC 2025

Prof (Dr) Hridayesh Prakash

Ph.D., FRSB

Deputy Director

Amity Center for Translational Research

Room No - 219 J-1 Block

Amity University Uttar Pradesh, NOIDA India